Mitochondrial Dysfunction and Neurodegeneration in Lysosomal Storage Disorders.

Area of Science:

• Biochemistry
• Cell Biology
• Genetics

Background:

• Lysosomal storage disorders (LSDs) are rare, inherited, and often fatal genetic diseases.
• LSDs result from mutations in lysosomal proteins, leading to the accumulation of undegraded materials and lysosomal dysfunction.
• Neurologic symptoms and neurodegeneration are common in LSDs, indicating significant impact on the central nervous system.

Purpose of the Study:

• To explore the intricate mechanisms linking lysosomal and mitochondrial dysfunction in LSDs.
• To assess the potential of targeting mitochondrial pathways as a novel therapeutic approach for LSDs.
• To understand the crosstalk between lysosomes and mitochondria in the context of LSD pathophysiology.

Main Methods:

• Literature review of studies investigating lysosomal and mitochondrial interactions.
• Analysis of signaling pathways common to both organelles in LSD models.
• Evaluation of existing and potential therapeutic interventions targeting mitochondrial function in LSDs.

Main Results:

• Emerging evidence highlights mitochondrial dysfunction as a key factor in LSD pathophysiology.
• Lysosomal dysfunction directly impacts mitochondrial health and function.
• Mitochondrial damage can reciprocally exacerbate lysosomal dysfunction, suggesting a vicious cycle.

Conclusions:

• The interplay between lysosomal and mitochondrial dysfunction is critical in LSDs.
• Targeting specific mitochondrial pathways may offer a promising therapeutic avenue for managing LSDs.
• Further research into organelle crosstalk could unlock new treatment strategies for these debilitating diseases.